Shuai ZQ, Zhang CX, Shuai ZW, et al (2021) Efficacy and safety of biological agents in the treatment of patients with Takayasu arteritis: a systematic review and meta-analysis
Today, there is no convincing explanation of how fatigue becomes long-lasting even after the brain injury or disease has healed
GLP-1 S is semaglutide, a long-acting and selective GLP-1 receptor agonist
Some individuals notice an energy boost within a few days , while others may take a few weeks for optimal effects
The arrhythmia research covers both ends of the potassium spectrum
Because appetite signaling, fat-mass regulation, and metabolic control are tightly linked, cagrilintide has become a useful research tool for studying how long-acting amylin agonism may influence weight-related biology and adipose-tissue function across integrated experimental systems [1][3][4]